PHAGEinLYON Clinic Cohort Study: a Descriptive Study of Severe Infections Treated With Phage Therapy at the HCL.

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorHospices Civils de Lyon

About this trial

PHAGEinLYON Clinic cohort study is a single site non-interventional retrospective and prospective study, initiated by the Hospices Civils de Lyon. Population targeted are patients with a severe infection treated with bacteriophage in the Hospices civils de Lyon from 2015 to 2033. The primary objective is to describe the severe infections treated with phagotherapy. 250 patients will be included in the study.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Patient with severe infection treated with bacteriophage in the Hospices Civils de Lyon from 01/01/2015 to 01/01/2033

PHAGEinLYON Clinic cohort study information notice provided to the patient

Disqualifiers

Opposition of trial participant

Trial population

250 patients with severe infection treated with phagotherapy will be included in the study.

Trial design

Design model

Cohort

Time perspective

Cross-sectional

Treatments tested in this trial

  • Description of severe infection

    Other intervention

    Description of severe infections treated with bacteriophage in the Hospices Civils de Lyon from 2015 to 2033.

Treatment groups

250 Participants
are divided into 1 treatment group
Group A: Patients with severe infection.1 intervention

Trial outcomes

Primary outcomes

1

Rate of each type of severe infection

Rate of each type of severe infection treated with bacteriophage in the Hospices Civils de Lyon from 2015 to 2033.

Time frame
through study completion (5years)

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.